Shopping Cart
Remove All
Your shopping cart is currently empty
(2S,3R)-Voruciclib, the (2S,3R)-enantiomer of Voruciclib, is an orally active CDK inhibitor.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,120 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,780 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $3,700 | 8-10 weeks | 8-10 weeks |
| Description | (2S,3R)-Voruciclib, the (2S,3R)-enantiomer of Voruciclib, is an orally active CDK inhibitor. |
| In vitro | The combination therapy of Gemcitabine, an EGFR kinase inhibitor, and (2S,3R)-Voruciclib (Compound B, formula I) is utilized for the treatment of pancreatic cancer. |
| Molecular Weight | 469.84 |
| Formula | C22H19ClF3NO5 |
| Cas No. | 1253731-24-6 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.